-
1
-
-
33845877140
-
Hepatotoxicity induced by cyproterone acetate: A report of three cases
-
Savidou I, Deutsch M, Soultati AS, et al. Hepatotoxicity induced by cyproterone acetate: a report of three cases. World J Gastroenterol 2006:12:7551-5.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7551-7555
-
-
Savidou, I.1
Deutsch, M.2
Soultati, A.S.3
-
2
-
-
0024492903
-
Fulminant hepatitis due to cyproterone acetate
-
Levesque H, Trivalle C, Manchon ND, et al. Fulminant hepatitis due to cyproterone acetate. Lancet 1989:1:215-6. http://dx.doi.org/10.1016/S0140-6736(89)91225-7
-
(1989)
Lancet
, vol.1
, pp. 215-216
-
-
Levesque, H.1
Trivalle, C.2
Manchon, N.D.3
-
3
-
-
0029902916
-
Severe hepatitis and liver failure induced by cyproterone acetate
-
Murphy BJ, Collins BJ. Severe hepatitis and liver failure induced by cyproterone acetate. Aust N Z J Med 1996:26:724. http://dx.doi.org/10.1111/j.1445-5994.1996.tb02956.x
-
(1996)
Aust N Z J Med
, vol.26
, pp. 724
-
-
Murphy, B.J.1
Collins, B.J.2
-
4
-
-
0036083998
-
Estrogen and cyproterone acetate combinationinduced autoimmune hepatitis
-
Kacar S, Akdogan M, Kosar Y, et al. Estrogen and cyproterone acetate combinationinduced autoimmune hepatitis. J Clin Gastroenterol 2002:35:98-100. http://dx.doi.org/10.1097/00004836-200207000-00023
-
(2002)
J Clin Gastroenterol
, vol.35
, pp. 98-100
-
-
Kacar, S.1
Akdogan, M.2
Kosar, Y.3
-
5
-
-
0026646685
-
Hepatitis due to cyproterone acetate
-
Drakos PE, Gez E, Catane R. Hepatitis due to cyproterone acetate. Eur J Cancer 1992;28A:1931-2. http://dx.doi.org/10.1016/0959-8049(92)90041-Y
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 1931-1932
-
-
Drakos, P.E.1
Gez, E.2
Catane, R.3
-
6
-
-
0029964843
-
Fatal sub-fulminant hepatitis caused by cyproterone acetate. A new case
-
Castellani P, Bernardini D, Renou C, et al. Fatal sub-fulminant hepatitis caused by cyproterone acetate. A new case. Gastroenterol Clin Biol 1996:20:915-6.
-
(1996)
Gastroenterol Clin Biol
, vol.20
, pp. 915-916
-
-
Castellani, P.1
Bernardini, D.2
Renou, C.3
-
7
-
-
0026308942
-
Fatal subfulminant hepatitis caused by cyproterone acetate
-
Antoni M, Bourliere M, Toullec J, et al. Fatal subfulminant hepatitis caused by cyproterone acetate. Gastroenterol Clin Biol 1991:15:772-3.
-
(1991)
Gastroenterol Clin Biol
, vol.15
, pp. 772-773
-
-
Antoni, M.1
Bourliere, M.2
Toullec, J.3
-
8
-
-
0025963329
-
Severe hepatocellular dysfunction following cyproterone acetate therapy
-
Parys BT, Hamid S, Thomson RG. Severe hepatocellular dysfunction following cyproterone acetate therapy. Br J Urol 1991:67:312-3. http://dx.doi.org/10.1111/j.1464-410X.1991.tb15142.x
-
(1991)
Br J Urol
, vol.67
, pp. 312-313
-
-
Parys, B.T.1
Hamid, S.2
Thomson, R.G.3
-
9
-
-
0032815714
-
Fatal fulminant hepatic failure due to cyproterone acetate
-
Friedman G, Lamoureux E, Sherker AH. Fatal fulminant hepatic failure due to cyproterone acetate. Dig Dis Sci 1999:44:1362-3. http://dx.doi.org/10.1023/A:1026639432428
-
(1999)
Dig Dis Sci
, vol.44
, pp. 1362-1363
-
-
Friedman, G.1
Lamoureux, E.2
Sherker, A.H.3
-
10
-
-
0028197442
-
Fatal fulminant hepatitis from cyproterone acetate
-
Hirsch D, Kovatz S, Bernheim J, et al. Fatal fulminant hepatitis from cyproterone acetate. Isr J Med Sci 1994:30:238-40.
-
(1994)
Isr J Med Sci
, vol.30
, pp. 238-240
-
-
Hirsch, D.1
Kovatz, S.2
Bernheim, J.3
-
11
-
-
0032039665
-
Acute hepatic necrosis in a patient treated with cyproterone acetate
-
Lombardi A, Ferrazza P, Castaldi F, et al. Acute hepatic necrosis in a patient treated with cyproterone acetate. G Chir 1998:19:161-3.
-
(1998)
G Chir
, vol.19
, pp. 161-163
-
-
Lombardi, A.1
Ferrazza, P.2
Castaldi, F.3
-
12
-
-
0027959577
-
Fatal hepatitis caused by cyproterone acetate
-
Bressollette L, Dubois A, Carlhant D, et al. Fatal hepatitis caused by cyproterone acetate. Therapie 1994:49:153.
-
(1994)
Therapie
, vol.49
, pp. 153
-
-
Bressollette, L.1
Dubois, A.2
Carlhant, D.3
-
13
-
-
84865072160
-
Unusually high alanine aminotransferase to aspartate aminotransferase ratio in a patient with cyproterone-induced icteric hepatitis
-
Hsu YC, Tai DI. Unusually high alanine aminotransferase to aspartate aminotransferase ratio in a patient with cyproterone-induced icteric hepatitis. Chang Gung Med J 2011:34(6 Suppl):34-8.
-
(2011)
Chang Gung Med J
, vol.34
, Issue.6
, pp. 34-38
-
-
Hsu, Y.C.1
Tai, D.I.2
-
14
-
-
84903452187
-
A case of fulminant hepatic failure due to cyproterone acetate in a patient with cryptogenic liver cirrhosis
-
Kim BH, Kim DJ, Sohn KM, et al. A case of fulminant hepatic failure due to cyproterone acetate in a patient with cryptogenic liver cirrhosis. Korean J Med 2009:77:S31-5.
-
(2009)
Korean J Med
, vol.77
, pp. S31-S35
-
-
Kim, B.H.1
Kim, D.J.2
Sohn, K.M.3
-
15
-
-
84871531559
-
Maximizing survival in metastatic castrate-resistant prostate cancer: A clinical viewpoint
-
Birtle A. Maximizing survival in metastatic castrate-resistant prostate cancer: A clinical viewpoint. Expert Rev Anticancer Ther 2013:13:89-99. http://dx.doi.org/10.1586/era.12.160
-
(2013)
Expert Rev Anticancer Ther
, vol.13
, pp. 89-99
-
-
Birtle, A.1
-
16
-
-
0030050569
-
Cyproterone acetate: Is it hepato-or genotoxic?
-
Rabe T, Feldmann K, Heinemann L, et al. Cyproterone acetate: is it hepato-or genotoxic? Drug Saf 1996:14:25-38. http://dx.doi.org/10.2165/00002018-199614010-00004
-
(1996)
Drug Saf
, vol.14
, pp. 25-38
-
-
Rabe, T.1
Feldmann, K.2
Heinemann, L.3
|